AzTrials
AzTrials

Muscle DamageNCT04748315

Recovery Kinetics After Speed-Εndurance Maintenance Training

A study testing SEMT(1:1) and SEMT (1:3) in people with Muscle Damage, run by University of Thessaly at 1 site in Greece.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study will be to inestigate the recovery kinetics on performance, neuromuscular fatigue and muscle microtaruma that will occur after two speed-endurance maintenance training protocols in elite male soccer players. Read more about this study

Who is it for?
Ages 18 to 35 years, men onlyHealthy volunteers can take part
Conditions the study is for
Muscle Damage
What is being tested?
SEMT(1:1) and SEMT (1:3)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteGreece
Study dates
1 Apr 2021to 31 Aug 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Aged between 18 and 35 years
  • Active soccer players who participate on a competitive soccer level at least for 4 years(≥5 sessions per week ≥1 match per week)
  • Free of chronic diseases
  • Free of musculoskeletal injury
  • Participants should be non-smokers

Who cannot join

  • Musculoskeletal injury
  • Chronic disease
  • Use of alcohol, caffeine and any type of ergogenic supplements or medication before (≥ 6 months) and throughout the study.

Trial locations and contacts

1 site in 1 country.

Greece1 site
  • University o Thessaly, School of Physical Education and Sports Science

    Trikala, 42100

Other trials in Greece

About this study

Official title: Recovery Kinetics After Speed-Εndurance Maintenance Training (SEMT) in Elite Male Soccer Players

The purpose of this study will be to inestigate the recovery kinetics on performance, neuromuscular fatigue and muscle microtaruma that will occur after two speed-endurance maintenance training protocols in elite male soccer players. Also, this study will determine the comparison between two different speed endurance maintenance protocols in neuromuscular fatigue, muscle microtrauma indicators and performance factors. The training protocols will be differentiated in training work to rest ratio. The firts training protocol trial will comprise the work to rest ratio (1:1) and the other trial will comprise the work to rest ratio 1:3.

Read the detailed description

Speed endurance maintenance training is utilized in order to improve the repeated sprint and high speed running ability of soccer players during a soccer match. Also, speed endurance maintenance training includes soccer drills which stimulate high speed and powerful actions such as changes of directions, accelerations and decelerations. However these actions are associated with eccentric component and it is known that eccentric exercises induces muscle damage microtrauma. Thus, the aim of this study will be to investigate the recovery kinetics on performance, neuromuscular fatigue and muscle microtrauma that will occur after two speed-endurance maintenance training protocols in elite male soccer players. The speed endurance maintenance training (SEMT) sessions will be differentiated in training volume and specifically in the work to rest period. Specifically, a randomized three-trial, cross-over, repeated measures design will be applied. Elite male soccer players (aged 18-35 years) will participate in the present study. Also, it is considered necessary that the participants will not suffer from any musculoskeletal injuries that will limit their ability to perform the SEMT sessions. Also the participants will not be smokers and will not consume alcohol and ergogenic nutritional supplements before and during the study.

In the first phase all participants will sign an informed consent form after they will be informed about all benefits and risks of this study and they will sign a recent historical of musculoskeletal injury or illness form. Subsequently, fasting blood samples will be collected by venipuncture using a disposable needle (10-gauge) in order to estimate muscle damage concentration markers (CK), blood lactate and inflammation markers (WBC). After, delayed onset muscle soreness (DOMS) in the knee flexors (KF) and extensors (KE) of both limbs, body weight (BW), height and body composition (DXA method) will be measured in the lab. Completing the first phase, participants will be instructed by a dietitian how to record a 7 days diet recalls estimating that the energy intake during the trials will be the same. The counter movement jump (CMJ) will be measured 24 hour after (second phase) on a force platform using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the data for each leg. During the CMJ will be measured the jump height (cm), the ground reaction force (N), the peak and mean power (W/kg), the vertical stiffness (Kvert, N/m/kg) and the peak rate of force development (RFD, N/s), while at the same time will be evaluated the change in peak and mean normalized EMG during the eccentric and concentric phases of the counter movement jump, for the vastus lateralis (VL), biceps femoris (BF), gastrocnemius (GAS), and gluteus maximus (GM) muscles. Electromyography data will be collected wirelessly at 2.000 Hz using a Myon MA-320 EMG system. The peak eccentric and concentric isokinetic torque of the knee flexors and extensors, in both limbs will be evaluated on an isokinetic dynamometer at 60°/sec. Also, the isometric peak torque of the knee extensors will be evaluated at 65o in both limbs. Also the fatigue rate during maximal voluntary isometric contraction will be estimated through the percent drop of peak torque between the first and the last three seconds of a 10-secong maximal isometric contraction. Also, the speed of 10m and 30m will be measured using light cells Chronojump system. The repeated sprint ability (RSA) (5x30m) will be measure using light cells Chronojump with 25 seconds rest in-between.

The soccer agility drill with a ball will be measured using light cells Chronojump in order to evaluate the soccer technical skills, 24 hour after. Finally, Open-circuit spirometry will be utilized for assessment of maximal oxygen consumption (VO2max) using an automated online pulmonary gas exchange system via breath-by-breath analysis during a graded exercise testing on a treadmill. The ability to recover after repeated intense exercise will be evaluated through the YO-YO Intermittent Recovery test level 2 and YO-YO Intermittent Endurance test level 2. 96 hours after, the participants are going to perform one of the two speed endurance maintenance training session randomly in the field. The SEMT(1:1) session will include 1 set, 6 repetitions per set and the work to rest ratio will be 1:1. The SEMT(1:3) session will iclude 1 set, 6 repetitions per set and the work to rest ratio will be 1:3. During the sessions will be assessed the change in Heart rate using a heart rate monitor and the field activity will be recorded using a global positiong system (GPS). The blood lactate will be evaluated immediately after each session. The DOMS indicator in the knee flexors (KF) and extensors (KE) of both limbs will be evaluated immediately after, 1h, 2h, 3h, 24h, 48h, and 72 hours after each session. The isometric peak torque of the knee extensors will be evaluated at 65° in limbs, post and at 1h, 2h and 3h, hours after each session. Also the fatigue rate during maximal voluntary isometric contraction will be estimated through the percent drop of peak torque between the first and the last three seconds of a 10-secong maximal isometric contraction.

Blood samples will be collected at 24h, 48h, and 72 hours after sessions. The counter movement jump (CMJ) will be measured immediately after the session, at 1h, 2h, 3h, at 24h, 48h and 72 hours after session on a force platform using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the data for each leg. During the CMJ will be measured the jump height (cm), the ground reaction force (N), the peak and mean power (W/kg), the vertical stiffness (Kvert, N/m/kg) and the peak rate of force development (RFD, N/s), while at the same time will be evaluated the change in peak and mean normalized EMG during the eccentric and concentric phases of the counter movement jump, for the vastus lateralis (VL), biceps femoris (BF), gastrocnemius (GAS), and gluteus maximus (GM) muscles. Electromyography data will be collected wirelessly at 2.000 Hz using a Myon MA-320 EMG system. Also, the speed of 10m and 30m will be measured using light cells Chronojump system immediately after, at 24h, 48h and 72 hours after session. Finally the RSA test will be measured at 24h, 48h and 72 hours after sessions. Α 2 - week washout period will be adapted among trials. After, the participants will perform the process until they complete the trials.

Conditions
Muscle Damage
Being tested
SEMT(1:1), SEMT (1:3)
Keywords
muscle damage, Eccentric exercise, Speed maintenance training, Soccer, Recovery

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SEMT(1:1)Other

    Soccer trainning protocolo will be performed on an work to rest ratio 1:1 and the trainning volume will consist of 1 set and 6 repetitions per set

  • SEMT (1:3)Other

    Soccer trainning protocolo will be performed on an work to rest ratio 1:3 and the trainning volume will consist of 1 set and 6 repetitions per set

Study groups in NCT04748315
Study groupRoleWhat they receive
SEMT(1:1)ExperimentalParticipants in this arm will perform an a speed endurance maintenance training consisted of work to rest ratio 1:1.
Receives: Other: SEMT(1:1)
SEMPT(1:3)ExperimentalParticipants in this arm will perform an a speed endurance maintenance training consisted of work to rest ratio 1:3.
Receives: Other: SEMT (1:3)
ControlNo interventionParticipants in this arm will receive no intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in white blood cell count

    White blood cell count will be measured using an automatic blood analyzer

    Measured: At baseline, at 24, 48 and 72 hours post speed endurance maintenance protocols.

  2. Change in Creatine kinase in blood

    Creatine kinase will be measured in plasma

    Measured: At baseline, at 24, 48 and 72 hours post speed endurance maintenance protocols.

  3. Change in countermovement jump height

    Countermovement jump height will be measured using two force platforms at 1000Hz, with each foot in parallel on the two platforms providing a seperate yet time-synchronized measurement of the jump height for each leg

    Measured: At baseline, post, 1, 2,3, 24, 48 and 72 hours post speed endurance maintenance protocols.

  4. Change in ground reaction force (GRF) during countermovement jump test

    The ground reaction force will be measured using two force platforms at 1000Hz, with each foot in parallel on the two platforms providing a seperate yet time-synchronized measurement of the jump height for each leg

    Measured: At baseline, at post, at 1, 2, 3, 24, 48 and 72 hours post speed endurance maintenance protocols.

  5. Change in peak power during countermovement jump test

    The peak power will be measured using two force platforms at 1000Hz, with each foot in parallel on the two platforms providing a seperate yet time-synchronized measurement of the jump height for each leg

    Measured: At baseline, post 1, 2, 3, 24, 48 and 72 hours post speed endurance maintenance protocols.

  6. Change in mean power during countermovement jump test

    The mean power will be measured using two force platforms at 1000Hz, with each foot in parallel on the two platforms providing a seperate yet time-synchronized measurement of the jump height for each leg

    Measured: At baseline, post, 1, 2, 3, 24, 48 and 72 hours post speed endurance maintenance protocols.

  7. Change in vertical stifness during countermovement jump test

    The vertical stifness will be measured using two force platforms at 1000Hz, with each foot in parallel on the two platforms providing a seperate yet time-synchronized measurement of the jump height for each leg

    Measured: At baseline, post, 1, 2, 3, 24, 48 and 72 hours post speed endurance maintenance protocols.

  8. Change in peak rate of force development during countermovement jump test

    The peak rate of force development will be measured using two force platforms at 1000Hz, with each foot in parallel on the two platforms providing a seperate yet time-synchronized measurement of the jump height for each leg

    Measured: At baseline, post, 1, 2, 3, 24, 48 and 72 hours post speed endurance maintenance protocols.

  9. Change in peak normalized EMG during the eccentric and concentric phases of the countermovement jmp test

    Electromyography data will be collected wirelessly at 2000Hz using a Myon MA-320 EMG system (Myon AG, Schwarzenberg, Switzerland) for the vastus lateralis (VL), biceps femoris (BF), gastrocnemius (GAS), and gluteus maximus (GM) muscles

    Measured: At baseline, post, 1, 2, 3, 24, 48 and 72 hours post speed endurance maintenance protocols.

  10. Change in mean normalized EMG during the eccentric and concentric phases of the countermovement jump test

    Electromyography data will be collected wirelessly at 2000Hz using a Myon MA-320 EMG system (Myon AG, Schwarzenberg, Switzerland) for the vastus lateralis (VL), biceps femoris (BF), gastrocnemius (GAS), and gluteus maximus (GM) muscles

    Measured: At baseline, post, 1, 2, 3, 24, 48 and 72 hours post speed endurance maintenance protocols.

  11. Change in delayed onset of muscle soreness

    Muscle soreness will be assessed during palpation of the muscle belly and the distal region

    Measured: At baseline, post, at 1, 2, 3, 24, 48 and 72 hours post speed endurance maintenance protocols.

  12. Change in repeated sprint ability (RSA)

    5 x 30 m sprints will be performed with 25 seconds rest in-between

    Measured: At baseline, at 24, 48 and 72 hours post speed endurance maintenance protocols.

  13. Change in sprint time of 10m

    Sprint time will be assessed over a 10m distance using light cells.

    Measured: At baseline, post, 24, 48 and 72 hours post speed endurance maintenance protocols.

  14. Change in sprint time of 30m

    Sprint time will be assessed over a 30m distance using light cells.

    Measured: At baseline, post, 24, 48 and 72 hours post speed endurance maintenance protocols.

  15. Change in field activity during the speed-endurance mainetnance protocols

    Field activity will be continuously recorded during both speed endurance maintenance protocols using global positioning system (GPS) technology

    Measured: For 20 minutes during the speed endurance maintenance training day

  16. Change in heart rate during the speed-endurance mainetnance protocols

    Heart rate will be continuously recorded during both speed endurance maintenance protocols using heart rate monitors

    Measured: For 20 minutes during the speed endurance maintenance training day

  17. Change in isometric peak torque

    The isometric peak torque will be assessed on an isokinetic dyanmometer

    Measured: At baseline, post, 1, 2, 3 and 24, 48 72 hours post speed endurance maintenance protocols.

  18. Change in fatigue index of maximal voluntary isometric contraction (MVIC) during 10 seconds

    Fatigue rate during MVIC will be estimated through the percent drop of peak torque between the first and the last three seconds of a 10-second maximal isometric contaction

    Measured: At baseline, post, 1, 2, 3 and 24, 48 72 hours post speed endurance maintenance protocols.

  19. Change in blood lactate

    The blood lactate will be measured using a lactate plus system

    Measured: At baseline and immediately post speed endurance maintenance protocols.

Secondary outcomes (9)
  1. Body weight

    Body weight will be measured on a beam balance with stadiometer

    Measured: At baseline

  2. Body height

    Body height will be measured on a beam balance with stadiometer

    Measured: At baseline

  3. Maximal oxygen consumption (VO2max)

    Maximal oxygen consumption will be measured by open circuit spirometry via breath by breath method

    Measured: At baseline

  4. Body fat

    Body fat will be measured by using Dual-emission X-ray absorptiometry

    Measured: At baseline

  5. Lean body mass

    Lean body mass will be measured by using Dual-emission X-ray absorptiometry

    Measured: At baseline

  6. Dietary intake

    Dietary intake will be assessed using 7 -day diet recalls

    Measured: Over a 7 -day period at baseline

  7. Soccer Agility drill

    The soccer agility drill will be assesed using light cells chronojump

    Measured: At baseline

  8. Yo-Yo Intermittent Recovery Test Level 2

    The Yo-Yo Intermittent Recovery Test Level 2 is considered as a maximal aerobic endurance fitness test, involving running between markers placed 20 meters apart, at increasing speeds, until exhaustion.

    Measured: At baseline

  9. Yo-Yo Intermittent endurance Test Level 2

    The Yo-Yo Intermittent endurance Test Level 2 evaluates an individual's aerobic endurance fitness, involving running between markers placed 20 meters apart, at increasing speeds, until exhaustion.

    Measured: At baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Feb 2021
  2. Study start1 Apr 2021
  3. Primary completion20 Apr 2023
  4. Study completion31 Aug 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Investigator
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04748315
Sponsor's protocol ID
Recovery-Maintenance-UTH
Status last verified
Jan 2024
First submitted
25 Jan 2021
Last updated
30 Jan 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing SEMT(1:1) and SEMT (1:3) in people with Muscle Damage, run by University of Thessaly at 1 site in Greece.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in white blood cell count (time frame: At baseline, at 24, 48 and 72 hours post speed endurance maintenance protocols.). The study lists 19 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in